US10017695B2 - Fluorinated dibenzofuran and dibenzothiophene derivatives - Google Patents

Fluorinated dibenzofuran and dibenzothiophene derivatives Download PDF

Info

Publication number
US10017695B2
US10017695B2 US15/095,229 US201615095229A US10017695B2 US 10017695 B2 US10017695 B2 US 10017695B2 US 201615095229 A US201615095229 A US 201615095229A US 10017695 B2 US10017695 B2 US 10017695B2
Authority
US
United States
Prior art keywords
denotes
compounds
formula
diyl
atoms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
US15/095,229
Other versions
US20160298034A1 (en
Inventor
Lars Lietzau
Constanze Brocke
Volker Reiffenrath
Atsutaka Manabe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Assigned to MERCK PATENT GMBH reassignment MERCK PATENT GMBH ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: MANABE, ATSUTAKA, BROCKE, CONSTANZE, LIETZAU, LARS, REIFFENRATH, VOLKER
Publication of US20160298034A1 publication Critical patent/US20160298034A1/en
Application granted granted Critical
Publication of US10017695B2 publication Critical patent/US10017695B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/34Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
    • C09K19/3491Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having sulfur as hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/91Dibenzofurans; Hydrogenated dibenzofurans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/76Dibenzothiophenes
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/34Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
    • C09K19/3402Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having oxygen as hetero atom
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/34Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
    • C09K19/3402Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having oxygen as hetero atom
    • C09K19/3405Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having oxygen as hetero atom the heterocyclic ring being a five-membered ring
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/42Mixtures of liquid crystal compounds covered by two or more of the preceding groups C09K19/06 - C09K19/40
    • GPHYSICS
    • G02OPTICS
    • G02FOPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F1/00Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
    • G02F1/01Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour 
    • G02F1/13Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour  based on liquid crystals, e.g. single liquid crystal display cells
    • G02F1/133Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
    • G02F1/1333Constructional arrangements; Manufacturing methods
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/34Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
    • C09K19/3402Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having oxygen as hetero atom
    • C09K19/3405Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having oxygen as hetero atom the heterocyclic ring being a five-membered ring
    • C09K2019/3408Five-membered ring with oxygen(s) in fused, bridged or spiro ring systems

Definitions

  • the present invention relates to fluorinated dibenzofuran and dibenzothiophene derivatives, to a process for the preparation thereof, to liquid-crystal (LC) media comprising these derivatives, and to electro-optical display elements containing these liquid-crystalline media.
  • LC liquid-crystal
  • Liquid crystals have found widespread use since the first commercially usable liquid-crystalline compounds were found about 30 years ago.
  • Known areas of application of conventional mixtures are, in particular, displays for watches and pocket calculators, and large display panels as used in railway stations, airports and sports arenas. Further areas of application are displays of portable and desktop computers, navigation systems and video applications. For the last-mentioned applications in particular, high demands are made of the response times and contrast of the images.
  • the spatial arrangement of the molecules in a liquid crystal has the effect that many of its properties are direction-dependent.
  • optical, dielectric and elastomechanical anisotropies are the optical, dielectric and elastomechanical anisotropies.
  • the di-electric constant ⁇ of the liquid-crystalline medium has different values for the two orientations.
  • Substances whose dielectric constant is larger when the longitudinal axes of the molecules are oriented perpendicular to the capacitor plates than when they are oriented parallel are referred to as dielectrically positive.
  • the dipole moment oriented along the longitudinal axis of the molecules is greater than the dipole moment oriented perpendicular to the longitudinal axis of the molecules.
  • liquid crystals in which the greater dipole moment is oriented parallel to the longitudinal axis of the molecule, very high-performance displays have already been developed. In most cases here, mixtures of from 5 to 20 components are used in order to achieve a sufficiently broad temperature range of the mesophase and short response times and low threshold voltages.
  • difficulties are still caused by the strong viewing angle dependence in liquid-crystal displays as are used, for example, for laptops.
  • the best imaging quality can be achieved if the surface of the display is perpendicular to the viewing direction of the observer. If the display is tilted relative to the observation direction, the imaging quality deteriorates drastically under certain circumstances.
  • they should have negative dielectric anisotropy, which makes them particularly suitable for use in liquid-crystalline media for VA displays.
  • dielectric anisotropy corresponding to the display type compounds are desired which have a favourable combination of the applicational parameters.
  • these parameters which are to be optimised simultaneously, particular mention should be made of a high clearing point, a low rotational viscosity, an optical anisotropy in the use range, and the properties which serve to achieve mixtures having the desired liquid-crystalline phases over a broad temperature range (lower melting point, good miscibility with other liquid-crystalline components of the desired type).
  • LC display modes which are also used, in particular, for small and medium-sized LC displays for use in portable devices, such as, for example, tablet PCs or so-called smartphones, are the IPS mode and the FFS (fringe field switching) mode, in which LC media having positive dielectric anisotropy are used.
  • the prior art discloses that the properties of a liquid-crystal display of the FFS type can be improved by adding liquid-crystal materials having negative dielectric anisotropy to highly polar LC media having positive dielectric anisotropy, causing the dielectric constant ⁇ perpendicular to the longitudinal molecular axes of the LC mixture to be increased (see EP 2 628 779 A2).
  • a further object of the present invention is therefore to provide compounds which, besides the above-mentioned advantageous applicational properties, have particularly high values of ⁇ at the same time as relatively low values of ⁇ .
  • must be as large as possible.
  • VA materials which are derived from dibenzofuran or from dibenzothiophene.
  • WO 02/055463 discloses compounds of the formula
  • X can denote, inter alia, O or S
  • Y can denote F
  • R 1 and R 2 can denote alkyl or alkoxy, and the other parameters have the meaning indicated therein.
  • the compounds described therein have negative dielectric anisotropy, but were developed for ferroelectric LC mixtures and no values for the dielectric anisotropies of the individual substances are described.
  • Y can denote O or S
  • the radical R 1 can denote alkoxy
  • R 2 can denote H
  • m and n can denote O
  • the radicals X 1 , X 2 and X 3 can denote F, as, for example, in the compound of Example No. 97
  • the compounds are highly polar and were developed as components for liquid-crystal mixtures for VA displays.
  • the compounds have negative ⁇ and are therefore suitable, in particular, for use in VA-TFT displays and very particularly as additives in IPS or FFS displays.
  • the compounds according to the invention preferably have a ⁇ between 0 and ⁇ 8, particularly preferably between ⁇ 2 and ⁇ 4, with values of ⁇ of preferably >10, particularly preferably >15.
  • is preferably >3, particularly preferably >5. They exhibit good miscibility with the usual substances used in liquid-crystal mixtures for displays, i.e. they have good solubility therein.
  • the rotational viscosity of the liquid-crystalline mixtures comprising the compounds of formula I is preferably 350 mPa ⁇ s or less, more preferably 250 mPa ⁇ s or less and particularly preferably 150 mPa ⁇ s or less.
  • the rotational viscosities of the compounds and of the resultant liquid-crystalline mixtures are advantageously low.
  • the other physical, physicochemical or electro-optical parameters of the compounds according to the invention are also advantageous for use of the compounds in liquid-crystalline media.
  • the liquid-crystalline media which comprise these compounds have, in particular, an adequate width of the nematic phase and good low-temperature and long-term stability as well as sufficiently high clearing points.
  • the low melting points of the compounds according to the invention give an indication of the advantageous mixing behaviour.
  • the compounds of the formula I according to the invention have values of the optical anisotropy ⁇ n which are suitable, in particular, for use in VA-TFT displays.
  • the compounds according to the invention preferably have a ⁇ n of greater than 0.15 and less than 0.25.
  • R preferably denotes an alkoxy radical, alkyl radical or alkenyl radical having 1 to 7 or 2 to 7 carbon atoms respectively.
  • R in the general formula I is particularly preferably an alkoxy radical or alkyl radical having 2 to 7 C atoms.
  • R preferably denotes an alkoxy group having 1-7 C atoms, particularly preferably having 2 to 5 C atoms.
  • R preferably denotes an alkyl, alkoxy or alkenyl group, particularly preferably an alkyl or alkenyl group having 1-7 C atoms, particularly preferably having 2 to 5 C atoms.
  • R represents an alkyl radical, this is straight-chain or branched.
  • R is preferably straight-chain and, unless indicated otherwise, has 1, 2, 3, 4, 5, 6 or 7 C atoms and is accordingly preferably methyl, ethyl, propyl, butyl, pentyl, hexyl or heptyl.
  • R represents an alkoxy radical, this is straight-chain or branched.
  • R is preferably straight-chain and, unless indicated otherwise, has 1, 2, 3, 4, 5, 6 or 7 C atoms and is accordingly preferably methoxy, ethoxy, propoxy, butoxy, pentoxy, hexoxy or heptoxy.
  • R in formula I can furthermore be an alkenyl radical having 2 to 15 C atoms, which is straight-chain or branched and contains at least one C—C double bond. It is preferably straight-chain and has 2 to 7 C atoms. It is accordingly preferably vinyl, prop-1- or -2-enyl, but-1-, -2- or -3-enyl, pent-1-, -2-, -3- or -4-enyl, hex-1-, -2-, -3-, -4- or -5-enyl, hept-1-, -2-, -3-, -4-, -5- or -6-enyl.
  • the alkenyl radical can be in the form of the E and/or Z isomer (trans/cis). In general, the respective E isomers are preferred. Of the alkenyl radicals, prop-2-enyl, but-2- or -3-enyl and pent-3- or -4-enyl are particularly preferred.
  • R in formula I can also be an alkynyl radical having 2 to 15 C atoms, which is straight-chain or branched and contains at least one C—C triple bond.
  • 1- or 2-propynyl and 1-, 2- or 3-propynyl are preferred.
  • the group A on each occurrence preferably denotes a disubstituted cyclic group selected from the formulae
  • the group Z preferably denotes a single bond, —CH 2 O—, —CF 2 O— or —OCF 2 —, particularly preferably —CH 2 O—.
  • the group W preferably denotes O.
  • the group Y preferably denotes —CF 3 or —OCF 3 , particularly preferably —OCF 3 .
  • the group L preferably denotes F, Cl, —CF 3 or an alkyl or alkoxy group having 1, 2 or 3 carbon atoms, particularly preferably F.
  • the parameter m preferably has a value of 0 or 1.
  • n denotes 0 and R denotes an alkoxy group having 1 to 7 carbon atoms.
  • Halogen in the context of the present invention denotes fluorine, chlorine, bromine or iodine, in particular fluorine or chlorine.
  • alkyl if not defined otherwise elsewhere in this description or in the claims—denotes a straight-chain or branched, saturated, aliphatic hydrocarbon radical having 1 to 15 carbon atoms.
  • Preferred compounds of the formulae Ia, Ib, Ic and Id are the compounds of the formulae Ia and Ib having the preferred sub-formulae Ia-1 and Ia-2,
  • R denotes a straight-chain alkoxy group having 1 to 5 C atoms, and Ib-1 and Ib-2,
  • R denotes a straight-chain alkyl or alkenyl group having 2 to 5 C atoms.
  • radicals or substituents of the compounds according to the invention or the compounds according to the invention themselves are in the form of optically active or stereoisomeric radicals, substituents or compounds respectively since they have, for example, a centre of asymmetry, these are likewise encompassed by the present invention.
  • the compounds of the general formula I according to the invention may exist in isomerically pure form, for example as pure enantiomers, diastereomers, E or Z isomers, trans or cis isomers, or as a mixture of a plurality of isomers in any desired ratio, for example as a racemate, E/Z isomer mixture or as a cis/trans isomer mixture.
  • the compounds of the general formula I can be prepared by methods known per se, as described in the literature (for example in the standard works, such as Houben-Weyl, Methoden der organischen Chemie [Methods of Organic Chemistry], Georg-Thieme-Verlag, Stuttgart), to be precise under reaction conditions which are known and suitable for the said reactions. Use can be made here of variants known per se which are not mentioned here in greater detail.
  • the starting materials can also be formed in situ by not isolating them from the reaction mixture, but instead immediately converting them further into the compounds of the general formula I.
  • the present invention in an embodiment also encompasses one or more processes for the preparation of compounds of the formula I.
  • the invention thus encompasses a process for the preparation of compounds of the formula I which is characterised in that it comprises a process step in which a compound of the formula II is converted into compounds of the formula I in the presence of a base, as shown in Scheme 2 and in which R, A, Z, X 1 , X 2 , W and m have the meaning indicated above and G denotes —OH, —SH or SG′ and G′ denotes a base-labile protecting group for thiols.
  • Preferred protecting groups are acetyl, dimethylaminocarbonyl, 2-tetrahydropyranyl, ethoxycarbonylethyl, tertbutyl, methyl, particularly preferably ethoxycarbonylethyl.
  • the process and the subsequent work-up of the reaction mixture can basically be carried out as a batch reaction or in a continuous reaction procedure.
  • the continuous reaction procedure encompasses, for example, reaction in a continuous stirred-tank reactor, a stirred-reactor cascade, a loop or cross-flow reactor, a flow tube or in a microreactor.
  • the reaction mixtures are optionally worked up, as necessary, by filtration via solid phases, chromatography, separation between immiscible phases (for example extraction), adsorption onto solid supports, removal of solvents and/or azeotropic mixtures by distillation, selective distillation, sublimation, crystallisation, co-crystallisation or by nanofiltration on membranes.
  • the compounds of the general formula I can be used in liquid-crystalline media.
  • the present invention therefore also relates to a liquid-crystalline medium comprising at least two liquid-crystalline compounds, comprising at least one compound of the general formula I.
  • the present invention also relates to liquid-crystalline media comprising 2 to 40, preferably 4 to 30, components as further constituents besides one or more compounds of the formula I according to the invention. These media particularly preferably comprise 7 to 25 components besides one or more compounds according to the invention.
  • These further constituents are preferably selected from nematic or nematogenic (monotropic or isotropic) substances, in particular substances from the classes of the azoxybenzenes, benzylideneanilines, biphenyls, terphenyls, 1,3-dioxanes, 2,5-tetrahydropyrans, phenyl or cyclohexyl benzoates, phenyl or cyclohexyl esters of cyclohexanecarboxylic acid, phenyl or cyclohexyl esters of cyclohexylbenzoic acid, phenyl or cyclohexyl esters of cyclohexylcyclohexanecar
  • L and E which may be identical or different, each, independently of one another, denote a divalent radical from the group formed by -Phe-, -Cyc-, -Phe-Phe-, -Phe-Cyc-, -Cyc-Cyc-, -Pyr-, -Dio-, -Thp-, -G-Phe- and -G-Cyc- and their mirror images, where Phe denotes unsubstituted or fluorine-substituted 1,4-phenylene, Cyc denotes trans-1,4-cyclohexylene or 1,4-cyclohexenylene, Pyr denotes pyrimidine-2,5-diyl or pyridine-2,5-diyl, Dio denotes 1,3-dioxane-2,5-diyl, Thp denotes tetrahydr
  • One of the radicals L and E is preferably Cyc or Phe.
  • E is preferably Cyc, Phe or Phe-Cyc.
  • the media according to the invention preferably comprise one or more components selected from the compounds of the formulae (II), (III), (IV), (V) and (VI) in which L and E are selected from the group consisting of Cyc and Phe and simultaneously one or more components selected from the compounds of the formulae (II), (III), (IV), (V) and (VI) in which one of the radicals L and E is selected from the group consisting of Cyc and Phe and the other radical is selected from the group consisting of -Phe-Phe-, -Phe-Cyc-, -Cyc-Cyc-, -G-Phe- and -G-Cyc-, and optionally one or more components selected from the compounds of the formulae (II), (III), (IV), (V) and (VI) in which the radicals L and E are selected from the group consisting
  • R′ and R′′ each, independently of one another, denote alkyl, alkenyl, alkoxy, alkoxyalkyl (oxaalkyl), alkenyloxy or alkanoyloxy having up to 8 C atoms.
  • This smaller sub-group is called group A below, and the compounds are referred to by the sub-formulae (IIa), (IIIa), (IVa), (Va) and (VIa).
  • R′ and R′′ are different from one another, one of these radicals usually being alkyl, alkenyl, alkoxy or alkoxyalkyl (oxaalkyl).
  • R′′ denotes —F, —Cl, —NCS or —(O) i CH 3-k F k , where i is 0 or 1 and k is 1, 2 or 3.
  • the compounds in which R′′ has this meaning are denoted by the sub-formulae (IIb), (IIIb), (IVb), (Vb) and (VIb).
  • R′′ has the meaning —F, —Cl, —NCS, —CF 3 , —OCHF 2 or —OCF 3 .
  • R′ is as defined for the compounds of the sub-formulae (IIa) to (VIa) and is preferably alkyl, alkenyl, alkoxy or alkoxyalkyl (oxaalkyl).
  • R′′ denotes —CN.
  • This sub-group is referred to below as group C, and the compounds of this sub-group are correspondingly described by sub-formulae (IIc), (IIIc), (IVc), (Vc) and (VIc).
  • R′ is as defined for the compounds of the sub-formulae (IIa) to (VIa) and is preferably alkyl, alkenyl, alkoxy or alkoxyalkyl (oxaalkyl).
  • the media according to the invention preferably comprise one or more compounds from groups A, B and/or C.
  • the proportions by weight of the compounds from these groups in the media according to the invention are:
  • the media according to the invention preferably comprise from 1 to 40%, particularly preferably from 5 to 30%, by weight of the compounds of the formula I according to the invention, based on the total weight of the composition.
  • the media preferably comprise one, two, three, four or five compounds of the formula I according to the invention.
  • the media according to the invention are prepared in a manner conventional per se.
  • the components are dissolved in one another, preferably at elevated temperature.
  • the liquid-crystalline phases of the present invention can be modified in such a way that they can be used in all types of liquid-crystal display element that have been disclosed hitherto.
  • Additives of this type are known to the person skilled in the art and are described in detail in the literature (H. Kelker/R. Hatz, Handbook of Liquid Crystals, Verlag Chemie, Weinheim, 1980).
  • pleochroic dyes can be added for the production of coloured guest-host systems or substances can be added in order to modify the dielectric anisotropy, the viscosity and/or the alignment of the nematic phases.
  • the compounds of the formula I are suitable for use in VA-TFT displays.
  • the value for ⁇ of compounds of formula I is preferably in the range from 10 to 50, more preferably in the range from 15-40 and particularly preferably in the range from 18 to 30. Owing to their high value for ⁇ , the compounds of the formula I are particularly suitable for use in FFS-TFT displays.
  • the present invention therefore also relates to electro-optical liquid-crystal display elements containing a liquid-crystalline medium according to the invention.
  • ⁇ n denotes the optical anisotropy (589 nm, 20° C.) and ⁇ denotes the dielectric anisotropy (1 kHz, 20° C.).
  • the dielectric anisotropy ⁇ is determined at 20° C. and 1 kHz.
  • the optical anisotropy ⁇ n is determined at 20° C. and a wavelength of 589.3 nm.
  • ⁇ and ⁇ n values and the rotational viscosity ( ⁇ 1 ) of the compounds according to the invention are obtained by linear extrapolation from liquid-crystalline mixtures consisting of 5 to 10% of the respective compound according to the invention and 90-95% of the commercially available liquid-crystal mixture ZLI-2857 (for ⁇ ) or ZLI-4792 (for ⁇ n, ⁇ 1 ) (mixtures, Merck KGaA, Darmstadt).
  • the batch is warmed to 0° C., and 30 ml of glacial acetic acid diluted with 38 ml of water are added. After 30 min. at room temp., 45 ml of a 35 percent hydrogen peroxide solution are added dropwise at a temperature between 35° C. and 40° C. After completion of the addition, the batch is kept at between 35° C. and 40° C. for 3 h, subsequently cooled to room temp., and water and MTB ether are added. The organic phase is washed with water and ammonium iron(II) sulfate solution, dried over sodium sulfate and evaporated. The residue is filtered through silica gel with n-pentane/dichloromethane, giving 6-bromo-2-fluoro-3-trifluoro-methoxyphenol as colourless oil.
  • Phenol 22 is prepared analogously to compound 14 by a Suzuki coupling from compound 13 and commercially available 4-butoxy-2,3-difluoro-benzeneboronic acid.
  • Triethylamine (5.0 ml) and DMAP (60 mg) are added dropwise to a solution of 3,2′,3′-trifluoro-4′-butyloxy-4-trifluoromethoxybiphenyl-2-ol (9.7 g) in dichloromethane (70 ml).
  • Trifluoromethanesulfonic anhydride (5.0 ml) is subsequently added dropwise at 5° C., and the reaction mixture is stirred at room temperature for 20 h. The mixture is filtered through silica gel, washed with dichloromethane, dried (Na 2 SO 4 ) and evaporated in vacuo.
  • 3,2′,3′-Trifluoro-4′-butyloxy-4-trifluoromethoxybiphenyl-2-yl trifluoro-methanesulfonate 9 is isolated as residue in the form of a pale-yellow oil.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Physics & Mathematics (AREA)
  • Nonlinear Science (AREA)
  • Mathematical Physics (AREA)
  • General Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Liquid Crystal Substances (AREA)
  • Furan Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Disclosed are dibenzofuran and dibenzothiophene derivatives of the general formula I,
Figure US10017695-20180710-C00001

in which X1, X2, W, Y, R, A, Z and m have the meaning defined in claim 1, to a process for the preparation thereof, to the use thereof as components in liquid-crystalline media, and to electro-optical display elements which contain the liquid-crystalline media according to the invention.

Description

FIELD OF THE INVENTION
The present invention relates to fluorinated dibenzofuran and dibenzothiophene derivatives, to a process for the preparation thereof, to liquid-crystal (LC) media comprising these derivatives, and to electro-optical display elements containing these liquid-crystalline media.
BACKGROUND OF THE INVENTION
Liquid crystals have found widespread use since the first commercially usable liquid-crystalline compounds were found about 30 years ago. Known areas of application of conventional mixtures are, in particular, displays for watches and pocket calculators, and large display panels as used in railway stations, airports and sports arenas. Further areas of application are displays of portable and desktop computers, navigation systems and video applications. For the last-mentioned applications in particular, high demands are made of the response times and contrast of the images.
The spatial arrangement of the molecules in a liquid crystal has the effect that many of its properties are direction-dependent. Of particular importance for use in liquid-crystal displays are the optical, dielectric and elastomechanical anisotropies. Depending on whether the molecules are oriented with their longitudinal axes perpendicular or parallel to the two plates of a capacitor, the latter has a different capacitance; in other words, the di-electric constant ε of the liquid-crystalline medium has different values for the two orientations. Substances whose dielectric constant is larger when the longitudinal axes of the molecules are oriented perpendicular to the capacitor plates than when they are oriented parallel are referred to as dielectrically positive. In other words, if the dielectric constant ε parallel to the longitudinal axes of the molecules is larger than the dielectric constant ε perpendicular to the longitudinal axes of the molecules, the dielectric anisotropy Δε=ε−ε is greater than zero. Most liquid crystals used in conventional displays fall into this group.
Both the polarisability of the molecule and the permanent dipole moment play a role for the dielectric anisotropy. On application of a voltage to the display, the longitudinal axis of the molecules orients itself in such a way that the larger of the dielectric constants becomes effective. The strength of the interaction with the electric field depends on the difference between the two constants.
In the case of the liquid-crystalline molecules used in conventional liquid-crystal displays, the dipole moment oriented along the longitudinal axis of the molecules is greater than the dipole moment oriented perpendicular to the longitudinal axis of the molecules.
By means of liquid crystals in which the greater dipole moment is oriented parallel to the longitudinal axis of the molecule, very high-performance displays have already been developed. In most cases here, mixtures of from 5 to 20 components are used in order to achieve a sufficiently broad temperature range of the mesophase and short response times and low threshold voltages. However, difficulties are still caused by the strong viewing angle dependence in liquid-crystal displays as are used, for example, for laptops. The best imaging quality can be achieved if the surface of the display is perpendicular to the viewing direction of the observer. If the display is tilted relative to the observation direction, the imaging quality deteriorates drastically under certain circumstances. For greater comfort, attempts are being made to maximise the angle through which the display can be tilted from the viewing direction of an observer without significantly reducing the imaging quality. Attempts have recently been made to improve the viewing-angle dependence using liquid-crystalline compounds whose dipole moment perpendicular to the longitudinal axis of the molecule is larger than that parallel to the longitudinal axis of the molecule. The dielectric anisotropy Δε is negative in this case. In the field-free state, these molecules are oriented with their longitudinal axis perpendicular to the glass surface of the display. Application of an electric field causes them to orient themselves more or less parallel to the glass surfaces. In this way, it has been possible to achieve an improvement in the viewing-angle dependence. Displays of this type are known as VA-TFT (“vertically aligned”) displays.
Development in the area of liquid-crystalline materials is still far from complete. In order to improve the properties of liquid-crystalline display elements, attempts are constantly being made to develop novel compounds which enable optimisation of such displays.
It is an object of the present invention to provide compounds having advantageous properties for use in liquid-crystalline media. In particular, they should have negative dielectric anisotropy, which makes them particularly suitable for use in liquid-crystalline media for VA displays. Irrespective of the dielectric anisotropy corresponding to the display type, compounds are desired which have a favourable combination of the applicational parameters. Of these parameters, which are to be optimised simultaneously, particular mention should be made of a high clearing point, a low rotational viscosity, an optical anisotropy in the use range, and the properties which serve to achieve mixtures having the desired liquid-crystalline phases over a broad temperature range (lower melting point, good miscibility with other liquid-crystalline components of the desired type).
Further LC display modes, which are also used, in particular, for small and medium-sized LC displays for use in portable devices, such as, for example, tablet PCs or so-called smartphones, are the IPS mode and the FFS (fringe field switching) mode, in which LC media having positive dielectric anisotropy are used. The prior art discloses that the properties of a liquid-crystal display of the FFS type can be improved by adding liquid-crystal materials having negative dielectric anisotropy to highly polar LC media having positive dielectric anisotropy, causing the dielectric constant ε⊥ perpendicular to the longitudinal molecular axes of the LC mixture to be increased (see EP 2 628 779 A2). Consequently, the high negative dielectric anisotropy of the admixed substances must be compensated again by a higher proportion of materials having positive dielectric anisotropy in order to produce the polarity of the mixture which is necessary for switching. There is therefore a need for LC mixture components which, although having a high ε∜, reduce the polarity of an LC mixture having positive Δε to a lesser extent owing to a relatively low Δε.
A further object of the present invention is therefore to provide compounds which, besides the above-mentioned advantageous applicational properties, have particularly high values of ε⊥ at the same time as relatively low values of Δε. In other words, the ratio of ε⊥ to |Δε| must be as large as possible.
Upon further study of the specification and appended claims, other objects, aspects and advantages of the invention will become apparent. The prior art discloses VA materials which are derived from dibenzofuran or from dibenzothiophene.
WO 02/055463 discloses compounds of the formula
Figure US10017695-20180710-C00002

in which X can denote, inter alia, O or S, Y can denote F, R1 and R2 can denote alkyl or alkoxy, and the other parameters have the meaning indicated therein. The compounds described therein have negative dielectric anisotropy, but were developed for ferroelectric LC mixtures and no values for the dielectric anisotropies of the individual substances are described.
Similar compounds are disclosed in DE 10 2004 021 691 A1, in which the group X generically includes polar radicals, such as F or —CF3, but preferably denotes H.
Figure US10017695-20180710-C00003
DE 10 2005 012 585 A1 describes, inter alia, dibenzofuran and dibenzothiophene compounds of the general formula
Figure US10017695-20180710-C00004

in which, inter alia, Y can denote O or S, the radical R1 can denote alkoxy, R2 can denote H, m and n can denote O and the radicals X1, X2 and X3 can denote F, as, for example, in the compound of Example No. 97
Figure US10017695-20180710-C00005
The compounds are highly polar and were developed as components for liquid-crystal mixtures for VA displays.
SUMMARY OF THE INVENTION
Surprisingly, it has been found that one or more of the objects described above can be achieved by compounds of the formula I
Figure US10017695-20180710-C00006
in which
    • W denotes O or S,
    • Y denotes F, Cl, CF3, OCF3 or OCF2H,
      • with the proviso that, if W denotes O, Y cannot be F,
    • X1, X2 denote H or F, with the proviso that at least one radical X1 or X2 denotes F,
    • R denotes an alkyl or alkoxy radical having 1 to 15 C atoms, where, in addition, one or more CH2 groups in these radicals may each be replaced, independently of one another, by —C≡C—, —CF2O—, —OCF2—, —CH═CH—,
Figure US10017695-20180710-C00007

—O—, —CO—O— or —O—CO— in such a way that O atoms are not linked directly to one another, and in which, in addition, one or more H atoms may be replaced by halogen,
    • A on each occurrence, identically or differently, denotes a radical selected from the following groups:
      • a) 1,4-phenylene, in which, in addition, one or two CH groups may be replaced by N and in which, in addition, one or more H atoms may be replaced by a group L,
      • b) the group consisting of trans-1,4-cyclohexylene and 1,4-cyclohexenylene, in which, in addition, one or more non-adjacent CH2 groups may be replaced by —O— and/or —S— and in which, in addition, one or more H atoms may be replaced by F or Cl, and
      • c) the group consisting of tetrahydropyran-2,5-diyl, 1,3-dioxane-2,5-diyl, tetrahydrofuran-2,5-diyl, cyclobutane-1,3-diyl, piperidine-1,4-diyl, thiophene-2,5-diyl and selenophene-2,5-diyl, each of which may also be mono- or polysubstituted by a group L,
    • L on each occurrence, identically or differently, denotes F, Cl, CN, SCN, SF5 or straight-chain or branched, and in each case optionally fluorinated, alkyl, alkoxy, alkylcarbonyl, alkoxycarbonyl, alkylcarbonyloxy or alkoxycarbonyloxy having 1 to 12 C atoms, and
    • Z on each occurrence, identically or differently, denotes a single bond, —CF2O—, —OCF2—, —CH2O—, —OCH2—, —(CO)O—, —O(CO)—, —(CH2)4—, —CH2CH2—, —CF2—CF2—, —CF2—CH2—, —CH2—CF2—, —CH═CH—, —CF═CF—, —CF═CH—, —CH═CF—, —(CH2)3O—, —O(CH2)3—, —C≡C—, —O—, —CH2—, —(CH2)3— or —CF2—,
    • m denotes 0, 1 or 2.
The compounds have negative Δε and are therefore suitable, in particular, for use in VA-TFT displays and very particularly as additives in IPS or FFS displays. The compounds according to the invention preferably have a Δε between 0 and −8, particularly preferably between −2 and −4, with values of ε⊥ of preferably >10, particularly preferably >15. The ratio ε⊥/|Δε| is preferably >3, particularly preferably >5. They exhibit good miscibility with the usual substances used in liquid-crystal mixtures for displays, i.e. they have good solubility therein. The rotational viscosity of the liquid-crystalline mixtures comprising the compounds of formula I is preferably 350 mPa·s or less, more preferably 250 mPa·s or less and particularly preferably 150 mPa·s or less. The rotational viscosities of the compounds and of the resultant liquid-crystalline mixtures are advantageously low.
The other physical, physicochemical or electro-optical parameters of the compounds according to the invention are also advantageous for use of the compounds in liquid-crystalline media. The liquid-crystalline media which comprise these compounds have, in particular, an adequate width of the nematic phase and good low-temperature and long-term stability as well as sufficiently high clearing points. The low melting points of the compounds according to the invention give an indication of the advantageous mixing behaviour. Furthermore, the compounds of the formula I according to the invention have values of the optical anisotropy Δn which are suitable, in particular, for use in VA-TFT displays. The compounds according to the invention preferably have a Δn of greater than 0.15 and less than 0.25.
DETAILED DESCRIPTION OF THE INVENTION
Exemplary embodiments of the present invention are described in detail below.
R preferably denotes an alkoxy radical, alkyl radical or alkenyl radical having 1 to 7 or 2 to 7 carbon atoms respectively. R in the general formula I is particularly preferably an alkoxy radical or alkyl radical having 2 to 7 C atoms. In the case where m=0, R preferably denotes an alkoxy group having 1-7 C atoms, particularly preferably having 2 to 5 C atoms.
In the case where m=1 or 2, R preferably denotes an alkyl, alkoxy or alkenyl group, particularly preferably an alkyl or alkenyl group having 1-7 C atoms, particularly preferably having 2 to 5 C atoms.
If R represents an alkyl radical, this is straight-chain or branched. R is preferably straight-chain and, unless indicated otherwise, has 1, 2, 3, 4, 5, 6 or 7 C atoms and is accordingly preferably methyl, ethyl, propyl, butyl, pentyl, hexyl or heptyl.
If R represents an alkoxy radical, this is straight-chain or branched. R is preferably straight-chain and, unless indicated otherwise, has 1, 2, 3, 4, 5, 6 or 7 C atoms and is accordingly preferably methoxy, ethoxy, propoxy, butoxy, pentoxy, hexoxy or heptoxy.
R in formula I can furthermore be an alkenyl radical having 2 to 15 C atoms, which is straight-chain or branched and contains at least one C—C double bond. It is preferably straight-chain and has 2 to 7 C atoms. It is accordingly preferably vinyl, prop-1- or -2-enyl, but-1-, -2- or -3-enyl, pent-1-, -2-, -3- or -4-enyl, hex-1-, -2-, -3-, -4- or -5-enyl, hept-1-, -2-, -3-, -4-, -5- or -6-enyl. If both C atoms of the C—C double bond are substituted, the alkenyl radical can be in the form of the E and/or Z isomer (trans/cis). In general, the respective E isomers are preferred. Of the alkenyl radicals, prop-2-enyl, but-2- or -3-enyl and pent-3- or -4-enyl are particularly preferred.
R in formula I can also be an alkynyl radical having 2 to 15 C atoms, which is straight-chain or branched and contains at least one C—C triple bond. 1- or 2-propynyl and 1-, 2- or 3-propynyl are preferred.
The group A on each occurrence, identically or differently, preferably denotes a disubstituted cyclic group selected from the formulae
Figure US10017695-20180710-C00008

in particular
Figure US10017695-20180710-C00009
The group Z preferably denotes a single bond, —CH2O—, —CF2O— or —OCF2—, particularly preferably —CH2O—.
The group W preferably denotes O.
For the groups X1 and X2, it is preferred for both to denote F.
The group Y preferably denotes —CF3 or —OCF3, particularly preferably —OCF3.
The group L preferably denotes F, Cl, —CF3 or an alkyl or alkoxy group having 1, 2 or 3 carbon atoms, particularly preferably F.
The parameter m preferably has a value of 0 or 1.
Particularly preferably, m denotes 0 and R denotes an alkoxy group having 1 to 7 carbon atoms.
Halogen in the context of the present invention denotes fluorine, chlorine, bromine or iodine, in particular fluorine or chlorine.
In connection with the present invention, the expression “alkyl”—if not defined otherwise elsewhere in this description or in the claims—denotes a straight-chain or branched, saturated, aliphatic hydrocarbon radical having 1 to 15 carbon atoms.
Particular preference is given to compounds of the formula I according to the invention selected from the sub-formulae Ia to Id,
Figure US10017695-20180710-C00010

where the radicals R, A, Z and Y have the meanings indicated above.
Preferred compounds of the formulae Ia, Ib, Ic and Id are the compounds of the formulae Ia and Ib having the preferred sub-formulae Ia-1 and Ia-2,
Figure US10017695-20180710-C00011

in which R denotes a straight-chain alkoxy group having 1 to 5 C atoms,
and Ib-1 and Ib-2,
Figure US10017695-20180710-C00012

in which R denotes a straight-chain alkyl or alkenyl group having 2 to 5 C atoms.
Very particular preference is given to compounds of the formulae Ia-1-1 to Ia-1-8 and Ib-1-1 to Ib-1-5,
Figure US10017695-20180710-C00013
Figure US10017695-20180710-C00014
If radicals or substituents of the compounds according to the invention or the compounds according to the invention themselves are in the form of optically active or stereoisomeric radicals, substituents or compounds respectively since they have, for example, a centre of asymmetry, these are likewise encompassed by the present invention. In this case, the compounds of the general formula I according to the invention may exist in isomerically pure form, for example as pure enantiomers, diastereomers, E or Z isomers, trans or cis isomers, or as a mixture of a plurality of isomers in any desired ratio, for example as a racemate, E/Z isomer mixture or as a cis/trans isomer mixture.
The 1,4-substituted cyclohexyl ring of the formula
Figure US10017695-20180710-C00015

or -Cyc- in the compounds disclosed for liquid-crystalline media preferably has the trans configuration, i.e. the two substituents are both in the equatorial position in the thermodynamically preferred chair conformation.
The compounds of the general formula I can be prepared by methods known per se, as described in the literature (for example in the standard works, such as Houben-Weyl, Methoden der organischen Chemie [Methods of Organic Chemistry], Georg-Thieme-Verlag, Stuttgart), to be precise under reaction conditions which are known and suitable for the said reactions. Use can be made here of variants known per se which are not mentioned here in greater detail.
If desired, the starting materials can also be formed in situ by not isolating them from the reaction mixture, but instead immediately converting them further into the compounds of the general formula I.
The syntheses of compounds of the general formula I according to the invention are described by way of example in the examples. The starting substances can be obtained by generally accessible literature procedures or are commercially available.
Particularly suitable synthetic routes to the compounds according to the invention are explained below with reference to Scheme 1.
Figure US10017695-20180710-C00016
Scheme 1 should only be regarded as illustrative. The person skilled in the art will be able to carry out corresponding variations of the syntheses presented, and also follow other suitable synthetic routes, in order to obtain compounds of the formula I.
In accordance with the synthesis depicted above, the present invention in an embodiment also encompasses one or more processes for the preparation of compounds of the formula I.
The invention thus encompasses a process for the preparation of compounds of the formula I which is characterised in that it comprises a process step in which a compound of the formula II is converted into compounds of the formula I in the presence of a base, as shown in Scheme 2 and in which R, A, Z, X1, X2, W and m have the meaning indicated above and G denotes —OH, —SH or SG′ and G′ denotes a base-labile protecting group for thiols. Preferred protecting groups are acetyl, dimethylaminocarbonyl, 2-tetrahydropyranyl, ethoxycarbonylethyl, tertbutyl, methyl, particularly preferably ethoxycarbonylethyl.
Figure US10017695-20180710-C00017
The process and the subsequent work-up of the reaction mixture can basically be carried out as a batch reaction or in a continuous reaction procedure. The continuous reaction procedure encompasses, for example, reaction in a continuous stirred-tank reactor, a stirred-reactor cascade, a loop or cross-flow reactor, a flow tube or in a microreactor. The reaction mixtures are optionally worked up, as necessary, by filtration via solid phases, chromatography, separation between immiscible phases (for example extraction), adsorption onto solid supports, removal of solvents and/or azeotropic mixtures by distillation, selective distillation, sublimation, crystallisation, co-crystallisation or by nanofiltration on membranes.
As already mentioned, the compounds of the general formula I can be used in liquid-crystalline media. The present invention therefore also relates to a liquid-crystalline medium comprising at least two liquid-crystalline compounds, comprising at least one compound of the general formula I.
The present invention also relates to liquid-crystalline media comprising 2 to 40, preferably 4 to 30, components as further constituents besides one or more compounds of the formula I according to the invention. These media particularly preferably comprise 7 to 25 components besides one or more compounds according to the invention. These further constituents are preferably selected from nematic or nematogenic (monotropic or isotropic) substances, in particular substances from the classes of the azoxybenzenes, benzylideneanilines, biphenyls, terphenyls, 1,3-dioxanes, 2,5-tetrahydropyrans, phenyl or cyclohexyl benzoates, phenyl or cyclohexyl esters of cyclohexanecarboxylic acid, phenyl or cyclohexyl esters of cyclohexylbenzoic acid, phenyl or cyclohexyl esters of cyclohexylcyclohexanecarboxylic acid, cyclohexylphenyl esters of benzoic acid, of cyclohexanecarboxylic acid or of cyclohexylcyclohexanecarboxylic acid, phenylcyclohexanes, cyclohexylbiphenyls, phenylcyclohexylcyclohexanes, cyclohexylcyclohexanes, cyclohexylcyclohexylcyclohexenes, 1,4-biscyclohexylbenzenes, 4′,4′-biscyclohexylbiphenyls, phenyl- or cyclohexylpyrimidines, phenyl- or cyclohexylpyridines, phenyl- or cyclohexyldioxanes, phenyl- or cyclohexyl-1,3-dithianes, 1,2-diphenylethanes, 1,2-dicyclohexylethanes, 1-phenyl-2-cyclohexylethanes, 1-cyclohexyl-2-(4-phenylcyclohexyl)ethanes, 1-cyclohexyl-2-biphenylethanes, 1-phenyl-2-cyclohexylphenylethanes, optionally halogenated stilbenes, benzyl phenyl ethers, tolans and substituted cinnamic acids. The 1,4-phenylene groups in these compounds may also be mono- or polyfluorinated.
The most important compounds suitable as further constituents of media according to the invention can be characterised by the formulae (II), (III), (IV), (V) and (VI):
R′-L-E-R″  (II)
R′-L-COO-E-R″  (III)
R′-L-OOC-E-R″  (IV)
R′-L-CH2CH2-E-R″  (V)
R′-L-CF2O-E-R″  (VI)
In the formulae (II), (III), (IV), (V) and (VI), L and E, which may be identical or different, each, independently of one another, denote a divalent radical from the group formed by -Phe-, -Cyc-, -Phe-Phe-, -Phe-Cyc-, -Cyc-Cyc-, -Pyr-, -Dio-, -Thp-, -G-Phe- and -G-Cyc- and their mirror images, where Phe denotes unsubstituted or fluorine-substituted 1,4-phenylene, Cyc denotes trans-1,4-cyclohexylene or 1,4-cyclohexenylene, Pyr denotes pyrimidine-2,5-diyl or pyridine-2,5-diyl, Dio denotes 1,3-dioxane-2,5-diyl, Thp denotes tetrahydropyran-2,5-diyl and G denotes 2-(trans-1,4-cyclo-hexyl)ethyl, pyrimidine-2,5-diyl, pyridine-2,5-diyl, 1,3-dioxane-2,5-diyl or tetrahydropyran-2,5-diyl.
One of the radicals L and E is preferably Cyc or Phe. E is preferably Cyc, Phe or Phe-Cyc. The media according to the invention preferably comprise one or more components selected from the compounds of the formulae (II), (III), (IV), (V) and (VI) in which L and E are selected from the group consisting of Cyc and Phe and simultaneously one or more components selected from the compounds of the formulae (II), (III), (IV), (V) and (VI) in which one of the radicals L and E is selected from the group consisting of Cyc and Phe and the other radical is selected from the group consisting of -Phe-Phe-, -Phe-Cyc-, -Cyc-Cyc-, -G-Phe- and -G-Cyc-, and optionally one or more components selected from the compounds of the formulae (II), (III), (IV), (V) and (VI) in which the radicals L and E are selected from the group consisting of -Phe-Cyc-, -Cyc-Cyc-, -G-Phe- and -G-Cyc-.
In a smaller sub-group of the compounds of the formulae (II), (III), (IV), (V) and (VI), R′ and R″ each, independently of one another, denote alkyl, alkenyl, alkoxy, alkoxyalkyl (oxaalkyl), alkenyloxy or alkanoyloxy having up to 8 C atoms. This smaller sub-group is called group A below, and the compounds are referred to by the sub-formulae (IIa), (IIIa), (IVa), (Va) and (VIa). In most of these compounds, R′ and R″ are different from one another, one of these radicals usually being alkyl, alkenyl, alkoxy or alkoxyalkyl (oxaalkyl).
In another relatively small sub-group of the compounds of the formulae (II), (III), (IV), (V) and (VI), known as group B, R″ denotes —F, —Cl, —NCS or —(O)iCH3-kFk, where i is 0 or 1 and k is 1, 2 or 3. The compounds in which R″ has this meaning are denoted by the sub-formulae (IIb), (IIIb), (IVb), (Vb) and (VIb). Particular preference is given to compounds of the sub-formulae (IIb), (IIIb), (IVb), (Vb) and (VIb) in which R″ has the meaning —F, —Cl, —NCS, —CF3, —OCHF2 or —OCF3.
In the compounds of group B, which are referred to by the sub-formulae (IIb), (IIIb), (IVb), (Vb) and (VIb), R′ is as defined for the compounds of the sub-formulae (IIa) to (VIa) and is preferably alkyl, alkenyl, alkoxy or alkoxyalkyl (oxaalkyl).
In a further smaller sub-group of the compounds of the formulae (II), (III), (IV), (V) and (VI), R″ denotes —CN. This sub-group is referred to below as group C, and the compounds of this sub-group are correspondingly described by sub-formulae (IIc), (IIIc), (IVc), (Vc) and (VIc). In the compounds of the sub-formulae (IIc), (IIIc), (IVc), (Vc) and (VIc), R′ is as defined for the compounds of the sub-formulae (IIa) to (VIa) and is preferably alkyl, alkenyl, alkoxy or alkoxyalkyl (oxaalkyl).
Besides the preferred compounds of groups A, B and C, other compounds of the formulae (II), (III), (IV), (V) and (VI) having other variants of the proposed substituents are also customary. All these substances are obtainable by methods which are known from the literature or analogously thereto.
Besides the compounds of the general formula I according to the invention, the media according to the invention preferably comprise one or more compounds from groups A, B and/or C. The proportions by weight of the compounds from these groups in the media according to the invention are:
Group A:
from 0 to 90%, preferably from 20 to 90%, in particular from 30 to 90%.
Group B:
from 0 to 80%, preferably from 10 to 80%, in particular from 10 to 70%.
Group C:
from 0 to 80%, preferably from 5 to 80%, in particular from 5 to 50%.
The media according to the invention preferably comprise from 1 to 40%, particularly preferably from 5 to 30%, by weight of the compounds of the formula I according to the invention, based on the total weight of the composition. The media preferably comprise one, two, three, four or five compounds of the formula I according to the invention.
The media according to the invention are prepared in a manner conventional per se. In general, the components are dissolved in one another, preferably at elevated temperature. By means of suitable additives, the liquid-crystalline phases of the present invention can be modified in such a way that they can be used in all types of liquid-crystal display element that have been disclosed hitherto. Additives of this type are known to the person skilled in the art and are described in detail in the literature (H. Kelker/R. Hatz, Handbook of Liquid Crystals, Verlag Chemie, Weinheim, 1980). For example, pleochroic dyes can be added for the production of coloured guest-host systems or substances can be added in order to modify the dielectric anisotropy, the viscosity and/or the alignment of the nematic phases.
Owing to their negative Δε, the compounds of the formula I are suitable for use in VA-TFT displays.
The value for ε⊥ of compounds of formula I is preferably in the range from 10 to 50, more preferably in the range from 15-40 and particularly preferably in the range from 18 to 30. Owing to their high value for ε⊥, the compounds of the formula I are particularly suitable for use in FFS-TFT displays.
The present invention therefore also relates to electro-optical liquid-crystal display elements containing a liquid-crystalline medium according to the invention.
Further combinations of the embodiments and variants of the invention in accordance with the description arise from the claims.
The invention is explained in greater detail below with reference to working examples, but without intending to be restricted thereby. The person skilled in the art will be able to glean from the examples working details that are not given in detail in the general description, generalise them in accordance with general expert knowledge and apply them to a specific problem.
Besides the usual and well-known abbreviations, the following abbreviations are used:
C: crystalline phase; N: nematic phase; Sm: smectic phase; I: isotropic phase. The numbers between these symbols show the transition temperatures of the substance concerned.
Temperature data are in ° C., unless indicated otherwise.
Physical, physicochemical or electro-optical parameters are determined by generally known methods, as described, inter alia, in the brochure “Merck Liquid Crystals—Licristal®—Physical Properties of Liquid Crystals—Description of the Measurement Methods”, 1998, Merck KGaA, Darmstadt.
Above and below, Δn denotes the optical anisotropy (589 nm, 20° C.) and Δε denotes the dielectric anisotropy (1 kHz, 20° C.). The dielectric anisotropy Δε is determined at 20° C. and 1 kHz. The optical anisotropy Δn is determined at 20° C. and a wavelength of 589.3 nm.
The Δε and Δn values and the rotational viscosity (γ1) of the compounds according to the invention are obtained by linear extrapolation from liquid-crystalline mixtures consisting of 5 to 10% of the respective compound according to the invention and 90-95% of the commercially available liquid-crystal mixture ZLI-2857 (for Δε) or ZLI-4792 (for Δn, γ1) (mixtures, Merck KGaA, Darmstadt).
The abbreviations above and below have the following meanings:
DMAP 4-(N,N-dimethylamino)pyridine
DMPU 1,3-dimethyl-3,4,5,6-tetrahydro-2(1H)-pyrimidinone
dpephos bis[2-(diphenylphosphino)phenyl] ether
dba dibenzylideneacetone
n-BuLi n-butyllithium, solution in hexane
MTB ether methyl tert-butyl ether
THF tetrahydrofuran
EXAMPLES
The present invention is described in detail by the following non-restrictive examples.
Example 1: 4,6-Difluoro-3-trifluoromethoxy-7-pentyloxydibenzofuran 1.1: 1,2-Difluoro-3-pentyloxybenzene
Figure US10017695-20180710-C00018
19.0 g (146 mmol) of 2,3-difluorophenol and 20.1 ml (163 mmol) of 1-bromopentane are dissolved in ethyl methyl ketone, 22.4 g of potassium carbonate are added, and the mixture is heated at the boil overnight. The solid is subsequently separated off, and the solvent is removed. The pentyl 2,3-difluorophenyl ether obtained is employed in the subsequent step without further purification.
1.2: 2,3-Difluoro-4-pentyloxybenzeneboronic acid
Figure US10017695-20180710-C00019
108 ml of a 15% solution of n-butyllithium in n-hexane (172 mmol) are added to a solution of 31.2 g of the crude product from step 1 (10) in 225 ml of THF at −70° C. After 1 h at this temperature, 20 ml (176 mmol) of trimethyl borate dissolved in 25 ml of THF are added. After a further hour, the batch is warmed to 0° C., water is added, and the mixture is adjusted to pH 1 using 25% hydrochloric acid. The aqueous phase is separated off and extracted with MTB ether. The combined organic phases are dried over sodium sulfate and evaporated. Crystallisation from n-heptane gives 2,3-difluoro-4-pentyloxybenzeneboronic acid as a colourless solid.
1.3: 6-Bromo-2-fluoro-3-trifluoromethoxyphenol
Figure US10017695-20180710-C00020
227 mmol of an LDA solution in 100 ml of THF, prepared from 32 ml of diisopropylamine and 143 ml of a 15% solution of n-butyllithium in n-hexane, are added to a solution of 33 ml (207 mmol) of 1-bromo-3-fluoro-4-trifluoromethoxybenzene (12) in 150 ml of THF at a temperature of −70° C. under nitrogen. After 1 h at the temperature, 26 ml (104 mmol) of trimethyl borate, dissolved in 50 ml of THF, are added to the batch. After a further hour, the batch is warmed to 0° C., and 30 ml of glacial acetic acid diluted with 38 ml of water are added. After 30 min. at room temp., 45 ml of a 35 percent hydrogen peroxide solution are added dropwise at a temperature between 35° C. and 40° C. After completion of the addition, the batch is kept at between 35° C. and 40° C. for 3 h, subsequently cooled to room temp., and water and MTB ether are added. The organic phase is washed with water and ammonium iron(II) sulfate solution, dried over sodium sulfate and evaporated. The residue is filtered through silica gel with n-pentane/dichloromethane, giving 6-bromo-2-fluoro-3-trifluoro-methoxyphenol as colourless oil.
1.4: 3,2′,3′-Trifluoro-4′-pentyloxy-4-trifluoromethoxybiphenyl-2-ol
Figure US10017695-20180710-C00021
1.8 g (13 mmol) of potassium carbonate, 6 ml of water and, at about 60° C., 40 mg (4 mmol) of tris(dibenzylideneacetone)dipalladium(0) and 50 mg of di-(1-adamantyl)butylphosphine are added to a solution of 3 g (80%, 9 mmol) of 6-bromo-2-fluoro-3-trifluoromethoxyphenol (13) in 15 ml of THF under nitrogen, and the mixture is subsequently heated to the boil. A solution of 2.6 g (97%, 10 mmol) of 2,3-difluoro-4-pentyloxybenzeneboronic acid (11) in 10 ml of THF is added dropwise at the boiling point. The batch is heated under reflux overnight and cooled, water and MTB ether are added, and the mixture is acidified using dil. hydrochloric acid. The aqueous phase is extracted with MTB ether. The combined organic phases are dried over sodium sulfate and evaporated, and the residue is filtered through silica gel with toluene, giving 3,2′,3′-trifluoro-4′-pentyloxy-4-trifluoromethoxybiphenyl-2-ol as colourless solid.
1.5: 4,6-Difluoro-3-trifluoromethoxy-7-pentyloxydibenzofuran
Figure US10017695-20180710-C00022
2.40 g (5.56 mmol) of 3,2′,3′-trifluoro-4′-pentyloxy-4-trifluoromethoxy-biphenyl-2-ol and 15.5 g (6.60 mmol) of potassium triphosphate monohydrate are left to stir overnight at 110° C. in 20 ml of DMPU. After cooling, the batch is diluted with MTB ether, washed with water and sat. sodium chloride solution and dried over sodium sulfate. The crude product is chromatographed on silica gel with toluene and recrystallised from toluene, giving 4,6-difluoro-3-trifluoromethoxy-7-pentyloxydibenzofuran as colourless crystals of m.p. 68° C.
The following compounds are prepared analogously to Example 1:
Figure US10017695-20180710-C00023
M.p. γ1
Ex. R [° C.] ε Δε Δn [mPa · s]
1 n-C5H11  68 19.81 −3.55 0.1361  68
2 CH3 112
3 C2H5 112
4 n-C3H7  97
5 n-C4H9  87
6 n-C6H13  72 20.84 −5.40 0.1393 100
The compound
Figure US10017695-20180710-C00024

known from the prior art has the following values:
Δε=−7.79
ε=24.69
ε/|Δε|=3.17
For Example 1, ε/|Δε|=5.58 is obtained.
For Example 6, ε/|Δε|=3.86 is obtained.
The comparison shows that the compounds according to the invention have much higher and thus more advantageous values for the ratio of ε to |Δε|.
The following compounds are prepared analogously to Example 1:
Figure US10017695-20180710-C00025
M.p. γ1
Ex. R [° C.] ε Δε Δn [mPa · s]
 7 CH3
 8 C2H5
 9 n-C3H7
10 n-C4H9
11 n-C5H11 46 16.29 −3.16 0.1113 59
12 n-C6H13
The following compounds are prepared analogously to Example 1:
Figure US10017695-20180710-C00026
M.p. γ1
Ex. R [° C.] ε Δε Δn [mPa · s]
13 CH3
14 C2H5
15 n-C3H7
16 n-C4H9
17 n-C5H11 74 23.66 −2.99 0.1333 85
18 n-C6H13 76 23.11 −3.76 0.1333 89
The following compounds are prepared analogously to Example 1:
Figure US10017695-20180710-C00027
M.p. γ1
Ex. R [° C.] ε Δε Δn [mPa · s]
19 CH3
20 C2H5
21 n-C3H7
22 n-C4H9
23 n-C5H11 46 18.84 2.17 0.1212 75
24 n-C6H13
Example 25: Butoxy-4,6-difluoro-7-trifluoromethoxydibenzothiophene 25.1: 3,2′,3′-Trifluoro-4′-butyloxy-4-trifluoromethoxybiphenyl-2-ol
Figure US10017695-20180710-C00028
Phenol 22 is prepared analogously to compound 14 by a Suzuki coupling from compound 13 and commercially available 4-butoxy-2,3-difluoro-benzeneboronic acid.
25.2: 3,2′,3′-Trifluoro-4′-butyloxy-4-trifluoromethoxybiphenyl-2-yl trifluoro-methanesulfonate
Figure US10017695-20180710-C00029
Triethylamine (5.0 ml) and DMAP (60 mg) are added dropwise to a solution of 3,2′,3′-trifluoro-4′-butyloxy-4-trifluoromethoxybiphenyl-2-ol (9.7 g) in dichloromethane (70 ml). Trifluoromethanesulfonic anhydride (5.0 ml) is subsequently added dropwise at 5° C., and the reaction mixture is stirred at room temperature for 20 h. The mixture is filtered through silica gel, washed with dichloromethane, dried (Na2SO4) and evaporated in vacuo. 3,2′,3′-Trifluoro-4′-butyloxy-4-trifluoromethoxybiphenyl-2-yl trifluoro-methanesulfonate 9 is isolated as residue in the form of a pale-yellow oil.
25.3: Ethyl 3-(4′-butoxy-3,2′,3′-trifluoro-4-trifluoromethoxybiphenyl-2-yl-sulfanyl)propionate
Figure US10017695-20180710-C00030
A solution of 3,2′,3′-trifluoro-4′-butyloxy-4-trifluoromethoxybiphenyl-2-yl trifluoromethanesulfonate (12.7 g) and ethyl 3-mercaptopropionate (3.8 ml) in toluene (55 ml) is heated under reflux under a nitrogen atmosphere, and bis(2-diphenylphosphinophenyl) ether (1.3 g), tris(dibenzylidene-acetone)dipalladium(0) (1.2 g), potassium carbonate (8.4 g) and a small amount of dried molecular sieve are added. The reaction mixture is heated under reflux for 20 h and subsequently cooled, and MTB ether and dist. water are added. The organic phase is separated off, dried (Na2SO4) and evaporated in vacuo. Purification of the residue by column chromatography (eluent toluene) gives ethyl 3-(4′-butoxy-3,2′,3′-trifluoro-4-trifluoro-methoxybiphenyl-2-ylsulfanyl)propionate as yellow oil.
25.4: Butoxy-4,6-difluoro-7-trifluoromethoxydibenzothiophene
Figure US10017695-20180710-C00031
2.50 g (22.3 mmol) of potassium tert-butoxide are initially introduced in 30 ml of THF, and a solution of 9.20 g (18.3 mmol) of ethyl 3-(4′-butoxy-3,2′,3′-trifluoro-4-trifluoromethoxybiphenyl-2-ylsulfanyl)propionate in 40 ml of THF is added dropwise at room temp. at such a rate that the temperature does not exceed 30° C. The batch is subsequently heated under reflux for 1 h, cooled, diluted with MTB ether and washed with water. The org. phase is dried over sodium sulfate, the solvent is removed in vacuo, and the residue is filtered through silica gel with toluene. Crystallisation of the crude product from ethanol gives 3-butoxy-4,6-difluoro-7-trifluoromethoxy-dibenzothiophene as colourless crystals of m.p. 121° C.
The following compounds are prepared analogously to Example 25:
Figure US10017695-20180710-C00032
M.p. γ1 Phase
Ex. R [° C.] ε Δε Δn [mPa · s] sequence
25 n-C4H9 121
26 CH3
27 C2H5 135
28 n-C3H7 138
29 n-C5H11  94 17.92 −3.97 0.1413 103 C 94 SmA 105 I
30 n-C6H13 114
The following compounds are prepared analogously to Example 25:
Figure US10017695-20180710-C00033
M.p. γ1
Ex. R [° C.] ε Δε Δn [mPa · s]
31 CH3
32 C2H5
33 n-C3H7
34 n-C4H9
35 n-C5H11 76
36 n-C6H13
The following compounds are prepared analogously to Example 25:
Figure US10017695-20180710-C00034
M.p. γ1
Ex. R [° C.] ε Δε Δn [mPa · s]
37 CH3
38 C2H5
39 n-C3H7
40 n-C4H9
41 n-C5H11 53 19.10 5.37 0.1293 81
42 n-C6H13
The following compounds are prepared analogously to Example 25:
Figure US10017695-20180710-C00035
M.p. γ1
Ex. R [° C.] ε Δε Δn [mPa · s]
43 CH3
44 C2H5
45 n-C3H7
46 n-C4H9
47 n-C5H11 75 0.1492 84
48 n-C6H13
The following compounds are prepared analogously to Example 25:
Figure US10017695-20180710-C00036
M.p. γ1
Ex. R [° C.] ε Δε Δn [mPa · s]
49 CH3
50 C2H5
51 n-C3H7
52 n-C4H9
53 n-C5H11 65
54 n-C6H13
The following compounds are prepared analogously to Example 25:
Figure US10017695-20180710-C00037
M.p. γ1
Ex. R [° C.] ε Δε Δn [mPa · s]
55 CH3
56 C2H5
57 n-C3H7
58 n-C4H9
59 n-C5H11 112
60 n-C6H13
Without further elaboration, it is believed that one skilled in the art can, using the preceding description, utilize the present invention to its fullest extent. The preceding preferred specific embodiments are, therefore, to be construed as merely illustrative, and not limitative of the remainder of the disclosure in any way whatsoever.
In the foregoing and in the examples, all temperatures are set forth uncorrected in degrees Celsius and, all parts and percentages are by weight, unless otherwise indicated.
The entire disclosures of all applications, patents and publications, cited herein and of corresponding German Patent Application No. DE 10 2015 004 505.9, filed Apr. 13, 2015 are incorporated by reference herein.
The preceding examples can be repeated with similar success by substituting the generically or specifically described reactants and/or operating conditions of this invention for those used in the preceding examples.
From the foregoing description, one skilled in the art can easily ascertain the essential characteristics of this invention and, without departing from the spirit and scope thereof, can make various changes and modifications of the invention to adapt it to various usages and conditions.

Claims (11)

The invention claimed is:
1. A compound of the formula I
Figure US10017695-20180710-C00038
in which
W denotes O or S,
Y denotes F, Cl, CF3, OCF3 or OCF2H,
with the proviso that, if W denotes O, Y cannot be F,
X1, X2 denote H or F,
with the proviso that at least one radical X1 or X2 denotes F,
R denotes an alkyl or alkoxy radical having 1 to 15 C atoms, where, in addition, one or more CH2 groups in these radicals may each be replaced, independently of one another, by —C≡C—, —CF2O—, —OCF2—, —CH═CH—,
Figure US10017695-20180710-C00039
—O—, —CO—O— or —O—CO— in such a way that O atoms are not linked directly to one another, and in which, in addition, one or more H atoms may be replaced by halogen,
A on each occurrence, identically or differently, denotes a radical selected from the following groups:
a) 1,4-phenylene, in which, in addition, one or two CH groups may be replaced by N and in which, in addition, one or more H atoms may be replaced by a group L,
b) the group consisting of trans-1,4-cyclohexylene and 1,4-cyclohexenylene, in which, in addition, one or more non-adjacent CH2 groups may be replaced by —O— and/or —S— and in which, in addition, one or more H atoms may be replaced by F or Cl, and
c) the group consisting of tetrahydropyran-2,5-diyl, 1,3-dioxane-2,5-diyl, tetrahydrofuran-2,5-diyl, cyclobutane-1,3-diyl, piperidine-1,4-diyl, thiophene-2,5-diyl and selenophene-2,5-diyl, each of which may also be mono- or polysubstituted by a group L,
L on each occurrence, identically or differently, denotes F, Cl, CN, SCN, SF5 or straight-chain or branched, and in each case optionally fluorinated alkyl, alkoxy, alkylcarbonyl, alkoxycarbonyl, alkylcarbonyloxy or alkoxycarbonyloxy having 1 to 12 C atoms, and
Z on each occurrence, identically or differently, denotes a single bond, —CF2O—, —OCF2—, —CH2O—, —OCH2—, —(CO)O—, —O(CO)—, —(CH2)4—, —CH2CH2—, —CF2—CF2—, —CF2—CH2—, —CH2—CF2—, —CH═CH—, —CF═CF—, —CF═CH—, —CH═CF—, —(CH2)3O—, —O(CH2)3—, —C≡C—, —O—, —CH2—, —(CH2)3— or —CF2—,
m denotes 0, 1 or 2.
2. A compound according to claim 1, wherein X1 and X2 both denote F.
3. A compound according to claim 1, wherein m denotes 0 or 1.
4. A compound according to claim 1, wherein Y in formula I denotes CF3 or OCF3.
5. A compound according to claim 4, wherein Y denotes OCF3.
6. A compound according to claim 1, wherein the compound of the formula I is selected from the compounds of sub-formulae Ia to Id,
Figure US10017695-20180710-C00040
in which R, A, Z and Y have the meanings indicated for formula I in claim 1.
7. A compound according to claim 1, wherein W denotes O.
8. A compound according to claim 1, wherein the compound is selected from the compounds of the following formulae:
Figure US10017695-20180710-C00041
Figure US10017695-20180710-C00042
9. Liquid-crystalline medium comprising at least two compounds, which comprises at least one compound according to claim 1.
10. Electro-optical display element containing a liquid-crystalline medium according to claim 9.
11. Process for the preparation of a compound of the formula I according to claim 1, comprising converting a compound of the formula II into a compound of the formula I
Figure US10017695-20180710-C00043
where R, A, Z, X1, X2, W, Y and m have the meaning indicated under claim 1 and G denotes —OH or —SG′, where G′ denotes H or a protecting group.
US15/095,229 2015-04-13 2016-04-11 Fluorinated dibenzofuran and dibenzothiophene derivatives Active US10017695B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102015004505.9 2015-04-13
DE102015004505 2015-04-13
DE102015004505 2015-04-13

Publications (2)

Publication Number Publication Date
US20160298034A1 US20160298034A1 (en) 2016-10-13
US10017695B2 true US10017695B2 (en) 2018-07-10

Family

ID=55642208

Family Applications (1)

Application Number Title Priority Date Filing Date
US15/095,229 Active US10017695B2 (en) 2015-04-13 2016-04-11 Fluorinated dibenzofuran and dibenzothiophene derivatives

Country Status (7)

Country Link
US (1) US10017695B2 (en)
EP (1) EP3085753B1 (en)
JP (1) JP6797544B2 (en)
KR (1) KR20160122081A (en)
CN (1) CN106045953B (en)
DE (1) DE102016003902A1 (en)
TW (1) TWI692475B (en)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170292072A1 (en) * 2016-04-07 2017-10-12 Merck Patent Gmbh Liquid-crystalline medium and liquid-crystal display comprising the same
US20180030020A1 (en) * 2014-03-17 2018-02-01 Merck Patent Gmbh 4,6-difluorodibenzofuran derivatives
US20190031958A1 (en) * 2017-07-27 2019-01-31 Merck Patent Gmbh Liquid-crystalline medium and liquid-crystal display comprising the same
US10774263B2 (en) 2017-09-26 2020-09-15 Merck Patent Gmbh Liquid-crystalline medium and liquid-crystal display comprising the same
US11168255B2 (en) 2018-07-12 2021-11-09 Merck Patent Gmbh Thiophene compound, liquid-crystalline medium and liquid-crystal display comprising the same
US20210403810A1 (en) * 2018-10-31 2021-12-30 Merck Patent Gmbh Dibenzofuran and dibenzothiophene derivatives
US11326102B2 (en) 2017-09-08 2022-05-10 Merck Patent Gmbh Liquid-crystalline medium and liquid-crystal display comprising the same
US11359142B2 (en) 2019-12-20 2022-06-14 Merck Patent Gmbh Liquid-crystalline medium and liquid-crystal display comprising the same
US11370969B2 (en) 2018-09-27 2022-06-28 Merck Patent Gmbh Liquid-crystal medium
US20230061307A1 (en) * 2018-12-19 2023-03-02 Merck Patent Gmbh Liquid-crystalline medium and liquid-crystal display comprising the same and compounds
US11891557B2 (en) 2017-09-14 2024-02-06 Merck Patent Gmbh Isothiocyanato tolane derivatives

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20160122074A (en) 2015-04-13 2016-10-21 메르크 파텐트 게엠베하 Liquid-crystalline medium and liquid-crystal display comprising the same
WO2017010281A1 (en) * 2015-07-15 2017-01-19 Jnc株式会社 Liquid crystal composition and liquid crystal display element
EP3541892B1 (en) 2016-11-18 2020-10-21 Merck Patent GmbH Liquid-crystalline medium and liquid-crystal display comprising the same
CN113913197B (en) * 2017-01-22 2023-08-08 石家庄诚志永华显示材料有限公司 Liquid crystal composition and liquid crystal display element or liquid crystal display comprising same
TWI744458B (en) * 2017-02-27 2021-11-01 日商捷恩智股份有限公司 Compound with dibenzofuran ring, liquid crystal composition and liquid crystal display element
JP7127295B2 (en) * 2017-03-13 2022-08-30 Jnc株式会社 Compound having fluorodibenzofuran ring, liquid crystal composition and liquid crystal display element
CN110461852B (en) * 2017-06-06 2022-10-28 Dic株式会社 Liquid crystal compound and composition thereof
CN110650948A (en) * 2017-06-06 2020-01-03 Dic株式会社 Liquid crystal compound and composition thereof
DE102018004237A1 (en) 2017-06-14 2018-12-20 Merck Patent Gmbh Dibenzofuran and dibenzothiophene derivatives
KR20200024242A (en) * 2017-06-28 2020-03-06 메르크 파텐트 게엠베하 2,3-dihydrobenzothiophene derivative
EP3421570B1 (en) * 2017-06-30 2020-11-11 Merck Patent GmbH Liquid-crystalline medium and liquid-crystal display comprising the same
DE102017006284A1 (en) * 2017-07-03 2019-01-03 Merck Patent Gmbh Thioether derivatives of dibenzothiophene and dibenzofuran
JP2019014675A (en) * 2017-07-06 2019-01-31 Dic株式会社 Phenyl phenol derivative and method for producing dibenzofuran derivative using the same
CN108264498B (en) * 2017-08-16 2021-02-26 石家庄诚志永华显示材料有限公司 Compound, liquid crystal medium containing compound and application of liquid crystal medium
CN109423296B (en) * 2017-08-24 2020-11-17 北京八亿时空液晶科技股份有限公司 Dibenzothiophene negative dielectric anisotropy compound and preparation method and application thereof
CN109423297B (en) * 2017-08-24 2020-08-11 北京八亿时空液晶科技股份有限公司 Dibenzothiophene liquid crystal compound and preparation method and application thereof
CN109423298B (en) * 2017-08-25 2020-09-11 北京八亿时空液晶科技股份有限公司 Novel dibenzothiophene liquid crystal compound and preparation method and application thereof
CN109486500B (en) * 2017-09-12 2023-08-08 石家庄诚志永华显示材料有限公司 Liquid crystal composition and liquid crystal display element or display thereof
WO2019052973A1 (en) 2017-09-14 2019-03-21 Merck Patent Gmbh Dibenzofuran and dibenzothiophene derivatives
CN111315847A (en) 2017-10-18 2020-06-19 默克专利股份有限公司 Liquid crystal medium and liquid crystal display comprising same
CN107794057B (en) * 2017-10-31 2021-03-23 晶美晟光电材料(南京)有限公司 Negative liquid crystal compound, liquid crystal mixture and application thereof
CN107722997A (en) * 2017-10-31 2018-02-23 晶美晟光电材料(南京)有限公司 Liquid-crystal compounds, liquid crystal compound and its application of negative permittivity
JP2021028299A (en) * 2017-11-30 2021-02-25 Jnc株式会社 Compound having dibenzothiophene ring, liquid crystal composition and liquid crystal display element
CN109666485B (en) * 2018-05-18 2021-08-27 石家庄诚志永华显示材料有限公司 Liquid crystal composition, liquid crystal display element and liquid crystal display
CN108865175B (en) * 2018-05-24 2020-05-15 石家庄晶奥量新材料有限公司 Liquid crystal composition containing dibenzofuran and application thereof
CN108531196B (en) * 2018-05-25 2020-11-06 石家庄晶奥量新材料有限公司 Liquid crystal compound containing dibenzofuran ring and preparation method and application thereof
CN110760313A (en) * 2018-07-26 2020-02-07 石家庄诚志永华显示材料有限公司 Liquid crystal compound, liquid crystal composition, liquid crystal display element and liquid crystal display
CN108865177B (en) * 2018-08-13 2020-06-09 石家庄晶奥量新材料有限公司 Liquid-crystalline medium and use in liquid-crystal displays
CN109370613B (en) * 2018-12-24 2020-11-03 石家庄晶奥量新材料有限公司 Liquid crystal composition and application thereof
CN111484853B (en) * 2019-01-29 2021-08-10 北京八亿时空液晶科技股份有限公司 Liquid crystal compound and preparation method and application thereof
CN111592517A (en) * 2019-02-20 2020-08-28 北京八亿时空液晶科技股份有限公司 Liquid crystal compound containing dibenzofuran structure and preparation method and application thereof
CN111592890B (en) * 2019-02-20 2021-09-28 北京八亿时空液晶科技股份有限公司 Liquid crystal compound and preparation method and application thereof
CN111592889B (en) * 2019-02-20 2021-09-28 北京八亿时空液晶科技股份有限公司 Liquid crystal compound and preparation method and application thereof
JP2020158503A (en) * 2019-03-25 2020-10-01 Jnc株式会社 Liquid crystalline compound having dibenzothiophene ring, liquid crystal composition and liquid crystal display element
CN110577833B (en) * 2019-08-15 2021-03-23 河北迈尔斯通电子材料有限公司 Negative liquid crystal compound and preparation method thereof
CN112980460A (en) * 2019-12-13 2021-06-18 北京八亿时空液晶科技股份有限公司 Liquid crystal compound and preparation method and application thereof
CN113122272A (en) * 2019-12-30 2021-07-16 石家庄诚志永华显示材料有限公司 Liquid crystal composition, liquid crystal display element and liquid crystal display
KR20210089100A (en) * 2020-01-07 2021-07-15 메르크 파텐트 게엠베하 Liquid-crystal medium
CN112175629B (en) * 2020-09-14 2023-03-24 北京八亿时空液晶科技股份有限公司 Terphenyl-containing fast response liquid crystal composition and application thereof
CN113234045B (en) * 2021-06-17 2023-05-02 烟台显华科技集团股份有限公司 Liquid crystal compound having negative dielectric anisotropy, liquid crystal composition, and liquid crystal display device
CN113403088B (en) * 2021-06-17 2022-12-30 烟台显华科技集团股份有限公司 Negative dielectric anisotropy liquid crystal composition and liquid crystal display device
CN113913193B (en) * 2021-07-23 2024-05-17 烟台显华科技集团股份有限公司 Liquid crystal compound having negative dielectric anisotropy, liquid crystal composition, and liquid crystal display device
CN114015461B (en) * 2021-12-21 2023-03-14 中节能万润股份有限公司 Liquid crystal monomer compound containing dibenzofuran and application thereof
CN114105921B (en) * 2021-12-22 2024-05-14 北京云基科技股份有限公司 Cyclopentyl benzofuran liquid crystal compound and application thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002055463A1 (en) 2001-01-11 2002-07-18 Clariant International Ltd. Fluorinated aromatic compounds and the use of the same in liquid crystal mixtures
DE102005012585A1 (en) 2004-04-14 2005-11-03 Merck Patent Gmbh New dibenzofuran-, dibenzothiophene- and fluorene derivatives useful in liquid crystalline media, which is useful in e.g. electro optical display elements
DE102004021691A1 (en) 2004-04-30 2005-11-24 Clariant International Limited Fluorinated heterocycles and their use in liquid crystal mixtures
US7018685B2 (en) * 2001-01-11 2006-03-28 Merck Patent Gmbh Fluorinated aromatic compounds and the use of the same in liquid crystal mixtures
US9512102B2 (en) * 2014-04-22 2016-12-06 Merck Patent Gmbh 4,6-difluorodibenzothiophene derivatives

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10101020A1 (en) * 2001-01-11 2002-07-18 Clariant Internat Ltd Muttenz Fluorinated fluorenes and their use in liquid-crystal mixtures
EP2628779B1 (en) 2012-02-15 2017-05-17 Merck Patent GmbH Liquid-crystalline medium

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002055463A1 (en) 2001-01-11 2002-07-18 Clariant International Ltd. Fluorinated aromatic compounds and the use of the same in liquid crystal mixtures
US7018685B2 (en) * 2001-01-11 2006-03-28 Merck Patent Gmbh Fluorinated aromatic compounds and the use of the same in liquid crystal mixtures
DE102005012585A1 (en) 2004-04-14 2005-11-03 Merck Patent Gmbh New dibenzofuran-, dibenzothiophene- and fluorene derivatives useful in liquid crystalline media, which is useful in e.g. electro optical display elements
US7514127B2 (en) * 2004-04-14 2009-04-07 Merck Patent Gmbh Dibenzofuran derivatives, dibenzothiophene derivatives and fluorene derivatives
US20050258399A1 (en) 2004-04-26 2005-11-24 Wolfgang Schmidt Fluorinated heterocycles and their use in liquid-crystal mixtures
DE102004021691A1 (en) 2004-04-30 2005-11-24 Clariant International Limited Fluorinated heterocycles and their use in liquid crystal mixtures
US7255900B2 (en) * 2004-04-30 2007-08-14 Merck Patent Gmbh Fluorinated heterocycles and their use in liquid-crystal mixtures
US9512102B2 (en) * 2014-04-22 2016-12-06 Merck Patent Gmbh 4,6-difluorodibenzothiophene derivatives

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
English translation Abstract of DE102004021691A1 published Nov. 24, 2005 (2 page).
English translation Abstract of DE102005012585A1 published Nov. 3, 2005 (2 page).
English translation Abstract of WO02055463A1 published Jul. 18, 2002 (2 page).
European Search Report dated Sep. 14, 2016, issued in corresponding EP Application No. 16000733, 6 pages.

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20180030020A1 (en) * 2014-03-17 2018-02-01 Merck Patent Gmbh 4,6-difluorodibenzofuran derivatives
US20170292072A1 (en) * 2016-04-07 2017-10-12 Merck Patent Gmbh Liquid-crystalline medium and liquid-crystal display comprising the same
US20190031958A1 (en) * 2017-07-27 2019-01-31 Merck Patent Gmbh Liquid-crystalline medium and liquid-crystal display comprising the same
US11326102B2 (en) 2017-09-08 2022-05-10 Merck Patent Gmbh Liquid-crystalline medium and liquid-crystal display comprising the same
US11891557B2 (en) 2017-09-14 2024-02-06 Merck Patent Gmbh Isothiocyanato tolane derivatives
US10774263B2 (en) 2017-09-26 2020-09-15 Merck Patent Gmbh Liquid-crystalline medium and liquid-crystal display comprising the same
US11168255B2 (en) 2018-07-12 2021-11-09 Merck Patent Gmbh Thiophene compound, liquid-crystalline medium and liquid-crystal display comprising the same
US11370969B2 (en) 2018-09-27 2022-06-28 Merck Patent Gmbh Liquid-crystal medium
US20210403810A1 (en) * 2018-10-31 2021-12-30 Merck Patent Gmbh Dibenzofuran and dibenzothiophene derivatives
US11667841B2 (en) * 2018-10-31 2023-06-06 Merck Patent Gmbh Dibenzofuran and dibenzothiophene derivatives
US20230061307A1 (en) * 2018-12-19 2023-03-02 Merck Patent Gmbh Liquid-crystalline medium and liquid-crystal display comprising the same and compounds
US11359142B2 (en) 2019-12-20 2022-06-14 Merck Patent Gmbh Liquid-crystalline medium and liquid-crystal display comprising the same

Also Published As

Publication number Publication date
DE102016003902A1 (en) 2016-10-13
CN106045953A (en) 2016-10-26
CN106045953B (en) 2021-06-11
EP3085753A1 (en) 2016-10-26
KR20160122081A (en) 2016-10-21
US20160298034A1 (en) 2016-10-13
JP6797544B2 (en) 2020-12-09
JP2016199543A (en) 2016-12-01
TWI692475B (en) 2020-05-01
EP3085753B1 (en) 2019-04-24
TW201708201A (en) 2017-03-01

Similar Documents

Publication Publication Date Title
US10017695B2 (en) Fluorinated dibenzofuran and dibenzothiophene derivatives
US9512102B2 (en) 4,6-difluorodibenzothiophene derivatives
US20210284911A1 (en) Electro-Optical Display Elements
US11236063B2 (en) Dibenzofuran derivatives and dibenzothiophene derivatives
US7514127B2 (en) Dibenzofuran derivatives, dibenzothiophene derivatives and fluorene derivatives
CN109996791B (en) Monofluorinated cyclohexane
US11667841B2 (en) Dibenzofuran and dibenzothiophene derivatives
US7744968B2 (en) Cyclobutane and spiro[3.3]heptane compounds
US7417157B2 (en) Hexahydrodibenzofuran derivatives
US20060202163A1 (en) Cyclopenta[a]naphthaline derivatives
US7182885B2 (en) Fluorinated indenes and 1,7-dihydroindacenes of negative dielectric anisotropy
US20070228328A1 (en) As-Indacen Derivatives
EP3645662B1 (en) 2,3-dihydrobenzothiophene derivatives
TWI757383B (en) Thioether compounds

Legal Events

Date Code Title Description
AS Assignment

Owner name: MERCK PATENT GMBH, GERMANY

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:LIETZAU, LARS;BROCKE, CONSTANZE;REIFFENRATH, VOLKER;AND OTHERS;SIGNING DATES FROM 20160421 TO 20160425;REEL/FRAME:038704/0883

STCF Information on status: patent grant

Free format text: PATENTED CASE

MAFP Maintenance fee payment

Free format text: PAYMENT OF MAINTENANCE FEE, 4TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1551); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

Year of fee payment: 4